Health Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Agilent Technologies, Inc.
TRADE NEWS: Agilent Technologies Introduces Human Copy Number Variation Microarrays Based on WTCCC Design Used In World’s Largest Study
April 24th, 2009
Agilent Technologies, Inc. (NYSE:A) today introduced the Human CNV Association 2x105K microarray for studying associations between genomic copy number variations (CNV) and disease. The array is based on a design by the Wellcome Trust Case Control Consortium (WTCCC), which is conducting the world’s largest study of CNVs and their relationships to a number of widespread disorders. “This array design is enriched for approximately 11,000 previously identified CNV locations along the genome,” said Chris Grimley, Agilent senior marketing director, Genomics. “The result is a highly validated, cost-effective CNV association tool, and we’re very pleased to be making it...
Source: Health Business Week (2009-04-24)
|
